Coronary interventions Relationship between Extent of Ischaemic Burden and Changes in Absolute Myocardial Perfusion after Chronic Total Occlusion Percutaneous Coronary Intervention Schumacher S, Kockx M, Stuijfzand W, Driessen R, van Diemen PA, Bom MJ, Everaars H, Raijmakers P, Boellaard R, van Rossum A, Opolski MP, Nap A, Knaapen P September 24, 2019 | 10.4244/EIJ-D-19-00631
Coronary interventions Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P June 20, 2017 | 10.4244/EIJ-D-16-01014
Coronary interventions Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial Stuijfzand W, Raijmakers P, Driessen R, Lammertsma A, van Rossum A, Nap A, Appelman Y, Lemkes J, van Leeuwen M, van Royen N, Knaapen P August 5, 2016 | 10.4244/EIJV12I5A98
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019